On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- NKT cells
- Innate and adaptive immune cells
- NKT cells: definition and classification
- Thymic development of "type 1" or iNKT cells
- Signaling required for iNKT cell development
- T cell antigen receptors of iNKT cells
- Remarkable level of conservation of iNKT cell TCRs
- CD1d basic features
- iNKT cells: natural & synthetic glycolipid antigens
- Alpha-GalCer cancer activity immunological basis
- Binding of Alpha-GalCer to CD1d
- CD1d tetramers for identification of NKT cells
- Identification of iNKT cells in tissues
- Phenotypic subsets of iNKT cells defined by CD4
- Functional differences between iNKT subsets cells
- Bacterial glycolipids recognized by NKT cells
- What lipids are presented by CD1d to iNKT cells?
- Comparison of foreign and self antigen by CD1d
- Basic features of iNKT cells: review
- What do iNKT cells do?
- Response to strong antigenic stimulus
- Cytokine production by human iNKT cell clone
- iNKT cell recognition of bacterial glycolipids
- INKT activation following infection
- Direct versus indirect activation of iNKT cells
- iNKT cells contribute to resistance to infection
- Anti-cancer effects of iNKT cell activation (1)
- Anti-cancer effects of iNKT cell activation (2)
- Different tissue iNKT cell & anticancer activity
- Different phenotypic subsets & anticancer activity
- Response to weak antigenic stimulus
- Cytokine production by NKT cell clone DN2.D5
- Diverse potential outcomes of NKT cell activation
- Anti-inflammatory/regulatory effects of iNKT cells
- Reduced NKT cells levels in autoimmune diseases
- High expression of CD1d in spleen marginal zone
- NKT cells regulate B cells
- Enhanced anti-PC responses after immunization
- Lupus, MZ B cells and iNKT cells?
- iNKT cells regulate autoreactive B cell responses
- Therapeutic manipulation of NKT cells
- Synthetic analogues of alpha-GalCer KRN7000
- Alpha-GalCer analogues
- "TH2-like" bias: C20:2 and OCH analogues
- Prevention of autoimmune type 1 diabetes mellitus
- Overall summary and conclusions
- Acknowledgments
Topics Covered
- Definition of NKT cells and their relation to other innate-like lymphocytes
- Development of NKT cells
- Mechanisms of glycolipid antigen recognition by NKT cells
- Frequency and phenotype of NKT cells
- Foreign and self antigens recognized
- Proinflammatory functions (anti-infectious and anti-tumor activities)
- Anti-inflammatory and tolerance-promoting functions
- Manipulation of NKT cell responses and therapeutic opportunities
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Porcelli, S.A. (2012, April 5). CD1d-restricted NKT cells: regulators of inflammation and autoimmunity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/ZERQ5342.Export Citation (RIS)
Publication History
- Published on April 5, 2012
Financial Disclosures
- Prof. Steven A. Porcelli, Consultant: Vaccinex, Inc. (Rochester, NY).
Hide